clinical trial · NCT05572034
Cardiac Autonomic Denervation for Cardio-inhibitory Syncope
Bradycardia; SyncopeSyncope, VasovagalElectrophysiological studyElectrophysiological study and Right side Ganglionated Plexi ablationElectrophysiological study and bi-atrial Ganglionated Plexi ablation
brief summary
Background: Autonomic system modification is an established therapeutic approach that has been increasingly used for the treatment of vagal-related symptomatic bradycardia, such as cardio-inhibitory vasovagal syncope1-12. Although convincing results had been reported from small populations, a large randomized study providing robust evidence on the efficacy of this approach has not yet been performed. Hypothesis: Cardiac autonomic system modification is effective for the treatment of vagal-related symptomatic bradycardia, and is associated better clinical results as compared to placebo.
started
Sep 1, 2023
primary completion
Dec 30, 2023
completion
Mar 30, 2024
last updated
Aug 18, 2023
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol